Oryzon Announces Completed Patient Recruitment in the PORTICO Phase IIb Trial of vafidemstat in Borderline Personality Disorder

Stock Information for Orion Group Holdings Inc. Common

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Orion Group Holdings Inc. Common

Orion Group Holdings to Participate in the Roth Capital Partners 14th Annual Deer Valley Event
Orion Group Holdings Announces Conference Participation
Orion Group Holdings Reports Third Quarter 2025 Results and Increases Fiscal Year 2025 Guidance
Orion Group Holdings to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
Orion Group Holdings Announces the Appointment of Robert Ledford to its Board of Directors
Orion Group Holdings Announces Over $120 Million in Contract Wins
Orion Group Holdings Reports Second Quarter 2025 Results and Reaffirms Fiscal Year 2025 Guidance
Orion Group Holdings to Report Second Quarter 2025 Financial Results on Tuesday, July 29

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.